Device Trial Radar · NCT05631652
Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -Healthy Volunteers Study
Last checked: Nov 19, 2026Latest source record: Nov 30, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Feb 11, 2021
Primary completion
Mar 11, 2021
Study completion Mar 11, 2021
Sponsor
- Lead sponsor
- EnteraSense LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 30, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of the investigation is to evaluate the feasibility of detecting blood in healthy volunteers after ingestion of autologous blood mixed with water.
Conditions
- Upper Gastrointestinal Bleeding
Interventions
PillSense SystemDevice
The device is composed of an orally ingested PillSense capsule and a wireless handheld PillSense receiver for real-time display of sensor data. The capsule contains an optical sensor for in-vivo detection of blood. The sensor capsule is used for diagnosis in patients with suspected acute bleeding in the upper gastrointestinal tract.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device ability to detect the absence of bloodTime frame: within 30 minutes
- Device ability to detect the presence of bloodTime frame: within 30 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Institut klinické a experimentální medicíny (IKEM),
Prague, Czechia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.